S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NYSE:MED

Medifast Stock Forecast, Price & News

$254.42
-6.94 (-2.66 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$252.28
Now: $254.42
$263.76
50-Day Range
$207.43
MA: $244.60
$274.30
52-Week Range
$49.03
Now: $254.42
$279.46
Volume101,172 shs
Average Volume125,470 shs
Market Capitalization$3.00 billion
P/E Ratio31.84
Dividend Yield1.73%
Beta1.52
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through direct ecommerce platform and franchise weight control center channels. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Medifast logo

Headlines

Medifast (MED) Q4 Earnings Match Estimates, Sales Surge Y/Y
February 26, 2021 |  finance.yahoo.com
Medifast: 4Q Earnings Snapshot
February 26, 2021 |  finance.yahoo.com
Medifast Inc (MED) Q4 2020 Earnings Call Transcript
February 26, 2021 |  finance.yahoo.com
Recap: Medifast Q4 Earnings
February 25, 2021 |  finance.yahoo.com
Medifast, Inc. to Host Earnings Call - Yahoo Finance
February 25, 2021 |  finance.yahoo.com
Recap: Medifast Q4 Earnings - Benzinga
February 25, 2021 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
CUSIP58470H10
Phone410-581-8042
Employees713
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$713.67 million
Cash Flow$7.93 per share
Book Value$9.03 per share

Profitability

Net Income$77.92 million

Miscellaneous

Market Cap$3.00 billion
Next Earnings Date5/4/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.33 out of 5 stars

Consumer Staples Sector

14th out of 301 stocks

Miscellaneous Food Preparations & Kindred Products Industry

1st out of 9 stocks

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 2.5Valuation: 2.5 5 -4 -3 -2 -1 -
$254.42
-6.94 (-2.66 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medifast (NYSE:MED) Frequently Asked Questions

Is Medifast a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medifast stock.
View analyst ratings for Medifast
or view top-rated stocks.

What stocks does MarketBeat like better than Medifast?

Wall Street analysts have given Medifast a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Medifast wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Medifast?

Medifast saw a decrease in short interest during the month of January. As of January 29th, there was short interest totaling 423,600 shares, a decrease of 23.8% from the January 14th total of 555,900 shares. Based on an average trading volume of 135,100 shares, the short-interest ratio is currently 3.1 days. Approximately 3.8% of the company's stock are short sold.
View Medifast's Short Interest
.

When is Medifast's next earnings date?

Medifast is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Medifast
.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) announced its quarterly earnings data on Thursday, February, 25th. The specialty retailer reported $2.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.36. Medifast had a net margin of 11.27% and a trailing twelve-month return on equity of 80.07%.
View Medifast's earnings history
.

How has Medifast's stock been impacted by Coronavirus?

Medifast's stock was trading at $70.44 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MED stock has increased by 261.2% and is now trading at $254.42.
View which stocks have been most impacted by COVID-19
.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Thursday, December 10th. Investors of record on Tuesday, December 22nd will be paid a dividend of $1.13 per share on Friday, February 5th. This represents a $4.52 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Monday, December 21st.
View Medifast's dividend history
.

Is Medifast a good dividend stock?

Medifast pays an annual dividend of $4.52 per share and currently has a dividend yield of 1.73%. Medifast does not yet have a strock track record of dividend growth. The dividend payout ratio of Medifast is 75.84%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, Medifast will have a dividend payout ratio of 43.38% next year. This indicates that Medifast will be able to sustain or increase its dividend.
View Medifast's dividend history.

What price target have analysts set for MED?

3 Wall Street analysts have issued 1 year price objectives for Medifast's stock. Their forecasts range from $265.00 to $310.00. On average, they expect Medifast's stock price to reach $292.33 in the next twelve months. This suggests a possible upside of 14.9% from the stock's current price.
View analysts' price targets for Medifast
or view top-rated stocks among Wall Street analysts.

Who are Medifast's key executives?

Medifast's management team includes the following people:
  • Mr. Daniel R. Chard, Exec. Chairman & CEO (Age 56, Pay $2.04M)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 49, Pay $582.79k)
  • Mr. Anthony Tyree, Chief Marketing Officer (Age 56, Pay $695.03k)
  • Mr. Nicholas M. Johnson, Pres of Coach & Client Experience (Age 41, Pay $564.54k)
  • Mr. James P. Maloney, Chief Financial Officer (Age 53)
  • Ms. Lauren Walker, Exec. VP of Supply Chain Operations
  • Mr. Stephen K. Johnson, VP of Fin. & Chief Accounting Officer (Age 41)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 50)
  • Ms. Claudia Greninger, Exec. VP of HR (Age 48)

What is Daniel Chard's approval rating as Medifast's CEO?

44 employees have rated Medifast CEO Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among Medifast's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Medifast's key competitors?

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), The Home Depot (HD), The Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (14.69%), Renaissance Technologies LLC (8.59%), Dimensional Fund Advisors LP (3.61%), Rice Hall James & Associates LLC (3.44%), Bank of New York Mellon Corp (1.84%) and Principal Financial Group Inc. (1.66%). Company insiders that own Medifast stock include Carl E Sassano, Jeffrey J Brown, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends for Medifast
.

Which institutional investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Schroder Investment Management Group, Dimensional Fund Advisors LP, Rice Hall James & Associates LLC, First Trust Advisors LP, Bank of New York Mellon Corp, Voloridge Investment Management LLC, Principal Financial Group Inc., and Principal Financial Group Inc.. Company insiders that have sold Medifast company stock in the last year include Michael C Macdonald, and Scott Schlackman.
View insider buying and selling activity for Medifast
or view top insider-selling stocks.

Which institutional investors are buying Medifast stock?

MED stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Morgan Stanley, BlackRock Inc., Lombard Odier Asset Management Switzerland SA, Landscape Capital Management L.L.C., Wells Fargo & Company MN, JPMorgan Chase & Co., and Healthcare of Ontario Pension Plan Trust Fund.
View insider buying and selling activity for Medifast
or or view top insider-buying stocks.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $254.42.

How much money does Medifast make?

Medifast has a market capitalization of $3.00 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis.

How many employees does Medifast have?

Medifast employs 713 workers across the globe.

What is Medifast's official website?

The official website for Medifast is www.medifast1.com.

Where are Medifast's headquarters?

Medifast is headquartered at 100 International Drive, Baltimore MD, 21202.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.